𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antibodies to histones and disease activity in systemic lupus erythematosus: A comparative study with an enzyme-linked immunosorbent assay and immunoblotting

✍ Scribed by K. Konstantinov; V. Russanova; V. Russeva


Publisher
Springer-Verlag
Year
1986
Tongue
English
Weight
811 KB
Volume
278
Category
Article
ISSN
0340-3696

No coin nor oath required. For personal study only.

✦ Synopsis


Enzyme-linked immunosorbent assay (ELISA) and immunoblotting were used to define comparatively the frequency of antibodies to total histones and different histone fractions -HI, H2A, H2B, H3, and H4 -in 16 patients with idiopathic systemic lupus erythematosns. HI and H2B showed the most prominent antigenic properties; H3's were weaker, while antibodies to H2A and H4 were rarely detected and only with the more sensitive ELISA on microtiter plates. Detailed specification was carried out of the antigenic determinant on fragments obtained by specific cleavage of purified H1 at phenylalanine-106. Antibodies were detected against both the NH2 and COOH terminal halves of the molecule. The presence of antihistone antibodies was not associated with any particular clinical symptoms, but an obvious link with disease activity has been proved.


πŸ“œ SIMILAR VOLUMES


Antibodies to sm in patients with system
✍ Franc A. Barada Jr.; Brian S. Andrews; John S. Davisiv; Ronald P. Taylor πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 748 KB

## Abstract Thirty patients with systemic lupus erythematosus (SLE( were studied over a 2.5‐year period. The group was divided into 14 patients with antibodies to Sm and a control group which failed to exhibit antibodies to Sm over the study period. The titer of antibodies to Sm fluctuated in all 1

Antibodies to apolipoprotein A-I, high-d
✍ Sean G. O'Neill; Ian Giles; Anastasia Lambrianides; Jessica Manson; David D'Cruz πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 163 KB πŸ‘ 2 views

## Abstract ## Objective Inflammatory disease activity in patients with systemic lupus erythematosus (SLE) may affect the development of atherosclerosis, contributing to their increased risk of cardiovascular disease (CVD). This process may be mediated by anti–apolipoprotein A‐I (anti–Apo A‐I), an